Search Results

Dongfang Electric's Nuclear Generator Sealing Patent Wins China Patent Excellence Award

The China National Intellectual Property Administration recently announced the award decision for the 26th China Patent Award. Dongfang Electric Group won the China Patent Excellence Award for three patents, among which "a full-path sealing structure for turbine generators and its assembly method" has been applied to nuclear power generating unit-related projects, demonstrating its innovative achievements in key technologies for nuclear power equipment. The patent, applied to the world's first Hualong One nuclear power generating unit, proposes a full-path sealing structure that breaks through the traditional intermittent sealing approach, constructing a continuous, uninterrupted sealing surface. By proactively preventing hydrogen leakage in generators, it reduces the risk of hydrogen explosion at the source. The related technology has achieved large-scale application and has been successfully used in the national major science and technology project Guohé One...

2026-09-02

Beijing Jiluntai's ¹⁷⁷Lu-JLT003 Injection Receives IND Approval for Treatment of Integrin αvβ3-Positive Malignant Tumors

Beijing Jiluntai Pharmaceutical Co., Ltd. has recently achieved progress in radiopharmaceutical R&D. Its self-developed Class 1 innovative therapeutic radiopharmaceutical ¹⁷⁷Lu-JLT003 Injection (generic name: ¹⁷⁷Lu-AB-3PRGD2) has obtained the Clinical Trial Approval (IND) from the Center for Drug Evaluation (CDE) of the National Medical Products Administration (NMPA), intended for the treatment of integrin αvβ3-positive malignant tumors. ¹⁷⁷Lu-AB-3PRGD2 is a therapeutic radiopharmaceutical targeting integrin αvβ3. Integrin αvβ3 is highly expressed on various solid tumor cells and tumor neovascular endothelial cells, while showing low expression in normal tissues, a characteristic that...

2026-09-01

Northeast Regional Office of the Ministry of Ecology and Environment Conducts Research on Radiation Risk Prevention and Control in the Scrap Metal Recycling and Smelting Industry

To strengthen radiation risk prevention and control across the entire chain of the scrap metal recycling and smelting industry and guide young cadres to conduct research and tackle challenges at the grassroots level, the Northeast Regional Office of Nuclear and Radiation Safety Supervision of the Ministry of Ecology and Environment (hereinafter referred to as the Northeast Regional Office) recently conducted special research at scrap metal resource recycling and steel smelting enterprises as well as customs ports. This research comprehensively mapped out the sources of scrap metal recycling, supply destinations, and the current status of radioactive monitoring management in the processing and sorting stages; focused on verifying the effectiveness of radiation monitoring requirements implementation at steel smelting enterprises, and meticulously examined the monitoring point deployment and control measures at key stages such as raw material entry, production process connection, and product shipment; further clarified the import and export radioactive monitoring management procedures, coordination and linkage working mechanisms, and the response and handling of abnormal events; and conducted in-depth exchanges and discussions with relevant units on some issues identified during the research.

2026-09-01

CNNC Headway's 13C-Urea Synthesis Control Method Patent Wins China Patent Excellence Award

On August 28, the China National Intellectual Property Administration officially released the decision on the 26th China Patent Award, and CNNC Headway's invention patent "A 13C-Urea Synthesis Control Method" won the China Patent Excellence Award. This patented technology addresses key technical bottlenecks in the batch production of carbon [13C]-urea API, establishing a set of synthesis control methods that provide technical support for the large-scale and stable production of the relevant API. The application of this technology helps enhance the self-sufficiency capability of the domestic urea [13C] breath diagnostic industry chain. CNNC Headway has long been deeply engaged in the breath diagnostic field, with sustained investment in innovative R&D, quality control, clinical adaptation, and industry chain layout...

2026-09-01

China-led International Standard for Estimating RBE-Weighted Absorbed Dose from Acute Exposure Approved for Initiation

According to the International Organization for Standardization (ISO), the international standard ISO25600 "Estimation Method for RBE (Relative Biological Effectiveness)-Weighted Absorbed Dose from Acute Exposure," led by the China Institute of Atomic Energy, has been officially approved for initiation. This is a general methodology international standard led by China in the global field of nuclear and radiation emergency dose assessment. It can provide important support for the rapid estimation and evaluation of acute doses, decision-making on emergency protective actions, international notification and communication, as well as emergency training, exercises, and scientific research, helping to strengthen the scientific rigor and timeliness of global nuclear emergency response, and enhance response capability and standardization. Nuclear and radiation emergency response is a vital guarantee for the sustained and healthy development of the nuclear energy industry...

2026-08-31

CGN and CSSC Deepen Cooperation in Nuclear Power and New Energy Sectors

On August 28, Pang Songtao, Deputy Secretary of the Party Committee and General Manager of China General Nuclear Power Group Co., Ltd. (CGN), met with Xu Peng and his delegation, Secretary of the Party Leadership Group and Chairman of China State Shipbuilding Corporation Limited (CSSC), at the CGN Tower. The two sides conducted in-depth exchanges on cooperation in areas such as nuclear power, new energy, industrial software, and technological innovation. Peng Yuanpu, Member of the Party Leadership Group and Deputy General Manager of CSSC, Ma Yunxiang, Assistant to the General Manager, Cai Zhen, Member of the Standing Committee of the Party Committee and Deputy General Manager of CGN, and Zhou Jianping, Member of the Party Committee of CGN, Vice President and General Counsel of CGN Power, attended the meeting. Pang Songtao extended a warm welcome to Xu Peng and his delegation. He noted that the cooperation between CGN and CSSC began with the Daya Bay Nuclear Power Plant and has spanned over four decades, with cooperation areas gradually expanding from nuclear power to environmental governance, new energy development, industrial software, and other fields, achieving fruitful results in areas such as nuclear emergency diesel generators and wind power equipment. Looking toward the “15th Five-Year Plan” period, he expressed the hope that both sides would further expand cooperation in new areas such as equipment manufacturing and technological innovation while consolidating the existing cooperation foundation, so as to better serve the national strategic agenda.

2026-08-31

Two Projects of the National Natural Science Foundation of China Approved for the National Institute for Radiological Protection, China CDC

On August 26, the National Natural Science Foundation of China (NSFC) announced the review results of the centralized application projects for the fiscal year 2026. The National Institute for Radiological Protection, China CDC, was approved for two NSFC projects, with research directions covering radon exposure monitoring, radiological health, and screening of lung cancer-related biomarkers. Among the approved projects, the proposal titled "New Strategy for Radon Exposure Monitoring: Visualization and Mechanism Study of Adsorption-Detection Integrated Gold Nanoparticle Materials" submitted by Associate Researcher Song Yanchao received support from the Department of Mathematical and Physical Sciences; the proposal titled "Preliminary Study and Validation of Screening Lung Cancer-Related Biomarkers in Radon-Exposed Miners Based on Methylation Chips and RNA-seq" submitted by Assistant Researcher Zhang Pinhua received support from the Department of Health Sciences.

2026-08-31

Domestically Produced Nuclear-Grade Resins Fully Verified and Ready for Use

On August 28, China General Nuclear Power Group (hereinafter referred to as CGN) announced that five nuclear-grade resin products developed under its leadership have all been put into engineering application, with a cumulative total of 12 batches used at nuclear power plants including Daya Bay, Ningde, Yangjiang, Taishan, and Hongyanhe. Among them, the first product has been operating stably for over three years in the steam generator blowdown system (APG system) of nuclear power plants, with key performance indicators comprehensively outperforming imported counterparts of the same category, and the domestic nuclear-grade resin production line. Nuclear-grade resins are known as the "kidneys" of nuclear power water treatment systems, serving as core materials that ensure stable water chemistry indicators of nuclear power units and prevent equipment corrosion. For a long time, these materials have been highly dependent on imports, posing supply security risks such as long delivery cycles, unstable batch quality, and rising prices year by year.

2026-08-29

China's First Enterprise-Level Synchrotron Radiation Technology Application Research Platform Inaugurated in Shanghai

The Sinopec Shanghai Synchrotron Radiation Facility Energy and Chemical Science Laboratory, invested by Sinopec and jointly built with the Shanghai Advanced Research Institute of the Chinese Academy of Sciences, and based on the Shanghai Synchrotron Radiation Facility (SSRF) major scientific infrastructure, was recently inaugurated in Shanghai Zhangjiang Science City. This laboratory is the first enterprise-level synchrotron radiation technology application research platform in China. According to reports, the laboratory consists of three beamline stations and auxiliary laboratories, and will provide technical support and services for basic scientific research conducted by Sinopec and public users, with a focus on oil and gas exploration and development, petroleum refining and chemical engineering, and new energy and new materials. Once the platform is completed, it will help enhance the enterprise's capabilities in forward-looking and fundamental research, and provide scientific research support for cultivating new quality productive forces in China's energy and chemical industry.

2026-08-29

China Isotope & Radiation Plans to Invest RMB 400 Million in Zhejiang Nuclear Technology Application Industry Fund

China Isotope & Radiation Corporation announced on August 28 that its board of directors has approved entering into a partnership agreement with CNNC, CNNC Capital, CNNC Fund, National Industry Investment Fund, Zhejiang Venture Capital Guidance Fund, Jiaxing Changchuang Industrial Investment, and Haiyan County State-owned Capital Investment to jointly establish CNNC (Zhejiang) Nuclear Technology Application Industry Investment Fund Partnership (Limited Partnership). According to the announcement, the fund will be registered in Jiaxing City, Zhejiang Province, with partners intending to subscribe to a total capital contribution of RMB 3 billion. Among them, China Isotope & Radiation plans to contribute RMB 400 million from internal resources, accounting for 13.33% of the fund's total subscribed capital; CNNC Fund, as the general partner, plans to contribute RMB 30 million, accounting for 1%; the National...

2026-08-29

CNNC Changchun Nuclear Medicine Base Obtains Production License

On August 28, the Jilin Provincial Drug Administration approved and issued the "Radiopharmaceutical Production License" to Changchun Atomic Hi-Tech Pharmaceutical Co., Ltd. (hereinafter referred to as "Changchun Hi-Tech"), a subsidiary of Atomic Hi-Tech under China Isotope & Radiation Corporation (CIRC). The acquisition of this license marks that Changchun Hi-Tech is now fully qualified for the production of technetium-labeled drugs. Radiopharmaceuticals are characterized by short half-lives, high transportation requirements, and strict time sensitivity. Long-distance transportation not only increases transportation and time costs but also poses greater challenges to the stability and timeliness of clinical medication. With the production qualification, Changchun Hi-Tech will be able to complete the production and distribution of technetium-labeled drugs locally in Jilin Province, which will help improve the clinical use of nuclear medicine in the Northeast region...

2026-08-29

CIAE Neutron Measurement Patent for Nuclear Waste Wins China Patent Excellence Award

On August 28, the results of the 26th China Patent Award, the highest government honor in China's intellectual property field, were announced. The invention patent for the calibration method of a neutron measurement device for drummed nuclear waste, completed by Zhu Liqun, Senior Engineer, and Xu Xiaoming, Associate Researcher, from the Department of Radiochemistry at the China Institute of Atomic Energy (CIAE), won the China Patent Excellence Award. Since 2020, CIAE has won the China Patent Award for six consecutive sessions, securing a total of 11 awards including 2 gold and 1 silver medals, further demonstrating the institute's formidable strength in technological innovation and intellectual property. The calibration method invention patent for the neutron measurement device for drummed nuclear waste has achieved multiple world firsts...

2026-08-29

China Unicom Yantai Branch and CNNC Shandong Build 5G Dedicated Network for Nuclear Power

Recently, the 5G dedicated network project jointly built by China Unicom Shandong Yantai Branch and CNNC Shandong was officially deployed and put into operation. Targeting the requirements of nuclear power scenarios for communication network security, reliability, and low latency, the project introduces technologies such as 5G dedicated networks, edge computing, artificial intelligence, and big data to promote the implementation of digital capabilities in nuclear power park construction and production support scenarios. CNNC Shandong, affiliated with China National Nuclear Corporation, undertakes tasks related to nuclear power unit power generation and grid connection. During project construction, China Unicom Shandong Yantai Branch, in collaboration with Huawei, adopted end-to-end domestically produced equipment, achieving independent controllability in both hardware and software, filling the gap in domestic 5G dedicated network construction in the nuclear power sector...

2026-08-28

Leadership Adjustment of Chairman and Party Secretary of China Huaneng Group Co., Ltd.

On August 28, 2026, China Huaneng Group Co., Ltd. held a meeting for management personnel at the middle level and above. A relevant official from the Organization Department of the CPC Central Committee announced the Party Central Committee's decision on the adjustment of the Chairman and Party Secretary of China Huaneng Group Co., Ltd.: Comrade Bai Yong was appointed as Chairman and Party Secretary of China Huaneng Group Co., Ltd., and was relieved of his duties as Director, President, and Deputy Party Secretary of COFCO Corporation; Comrade Wen Shugang was relieved of his duties as Chairman and Party Secretary of China Huaneng Group Co., Ltd. The relevant appointments and removals shall be handled in accordance with applicable laws and the company's articles of association...

2026-08-28

CNNC Fuyuan (Beijing) Technology Co., Ltd. officially established, focusing on accelerator and radiation technology equipment

On August 26, 2026, CNNC Fuyuan (Beijing) Technology Co., Ltd. (abbreviated as: CNNC Fuyuan) was officially established. CNNC Fuyuan is a joint venture between China Isotope & Radiation Corporation (CIRC) and CNNC Atomic Energy Institute Technology Co., Ltd., with nuclear technology equipment as its core business and radiation technology empowering industrial upgrading. Leveraging the Atomic Energy Institute's profound accumulation in accelerator technology over more than 70 years, as well as CIRC's market-oriented industrialization capabilities, the company builds a deeply integrated industry closed loop encompassing research, education, application, and utilization, strengthening and complementing the nuclear technology equipment industry chain. Looking ahead, CNNC Fuyuan will adhere to the dual-drive approach of independent innovation and achievement transformation, starting with accelerators, breaking through the boundaries of single products, and extending toward full-spectrum radiation technology,...

2026-08-28